TLSA
Price:
$0.9071
Market Cap:
$95.60M
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL...[Read more]
Industry
Biotechnology
IPO Date
2018-11-20
Stock Exchange
NASDAQ
Ticker
TLSA
According to Tiziana Life Sciences Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 1.12. This represents a change of -47.93% compared to the average of 2.15 of the last 4 quarters.
The mean historical Current Ratio of Tiziana Life Sciences Ltd over the last ten years is 4.07. The current 1.12 Current Ratio has changed 2.66% with respect to the historical average. Over the past ten years (40 quarters), TLSA's Current Ratio was at its highest in in the December 2015 quarter at 12.40. The Current Ratio was at its lowest in in the December 2010 quarter at 0.
Average
4.07
Median
3.25
Minimum
0.21
Maximum
12.40
Discovering the peaks and valleys of Tiziana Life Sciences Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.19%
Maximum Annual Current Ratio = 12.40
Minimum Annual Increase = -82.16%
Minimum Annual Current Ratio = 0.21
Year | Current Ratio | Change |
---|---|---|
2023 | 1.12 | -69.21% |
2022 | 3.64 | -43.51% |
2021 | 6.45 | -26.65% |
2020 | 8.79 | 4.19% |
2019 | 0.21 | -81.02% |
2018 | 1.08 | 109.44% |
2017 | 0.52 | -82.16% |
2016 | 2.89 | -76.68% |
2015 | 12.40 | 244.26% |
2014 | 3.60 | 677.52% |
The current Current Ratio of Tiziana Life Sciences Ltd (TLSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.74
5-year avg
4.04
10-year avg
4.07
Tiziana Life Sciences Ltd’s Current Ratio is less than Clearmind Medicine Inc. (0), less than Hillstream BioPharma, Inc. (1.71), less than Coeptis Therapeutics, Inc. (2.25), greater than Magenta Therapeutics, Inc. (0.55), less than Quoin Pharmaceuticals, Ltd. (14.64), less than Affimed N.V. (3.35), less than Leap Therapeutics, Inc. (2.71), less than Adaptimmune Therapeutics plc (5.10), less than Corvus Pharmaceuticals, Inc. (3.09), less than Aptose Biosciences Inc. (3.62), greater than Bionomics Limited (0.80), less than Accustem Sciences Inc. (3.45), greater than Comera Life Sciences Holdings, Inc. (0.12), greater than SciSparc Ltd. (0.90), less than Biohaven Pharmaceutical Holding Company Ltd. (4.10), less than Immunome, Inc. (3.27), less than Inhibrx Biosciences, Inc. (7.12), less than AgeX Therapeutics, Inc. (6.20), greater than Icosavax, Inc. (0.64), less than null (18.06),
Company | Current Ratio | Market cap |
---|---|---|
0 | $5.68M | |
1.71 | $4.17M | |
2.25 | $7.99M | |
0.55 | $42.44M | |
14.64 | $2.86M | |
3.35 | $49.79M | |
2.71 | $140.43M | |
5.10 | $204.51M | |
3.09 | $564.21M | |
3.62 | $7.20M | |
0.80 | $3.41M | |
3.45 | $3.52M | |
0.12 | $3.07K | |
0.90 | $2.31M | |
4.10 | $5.05B | |
3.27 | $769.30M | |
7.12 | $225.10M | |
6.20 | $27.76M | |
0.64 | $769.04M | |
18.06 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tiziana Life Sciences Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tiziana Life Sciences Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tiziana Life Sciences Ltd's Current Ratio?
How is the Current Ratio calculated for Tiziana Life Sciences Ltd (TLSA)?
What is the highest Current Ratio for Tiziana Life Sciences Ltd (TLSA)?
What is the 3-year average Current Ratio for Tiziana Life Sciences Ltd (TLSA)?
What is the 5-year average Current Ratio for Tiziana Life Sciences Ltd (TLSA)?
How does the current Current Ratio for Tiziana Life Sciences Ltd (TLSA) compare to its historical average?